Joel Ernst, MD, professor of medication and chief of the division of experimental drugs, UCSF College of Drugs, San Francisco.

Santosha Vardhana, MD, PhD, assistant professor of medication and attending doctor, Memorial Sloan Kettering Most cancers Heart, New York.

Nicolas Vabret, PhD, assistant professor of medication, Icahn College of Drugs at Mount Sinai, New York.

Medline Plus: “Immune response.” 

Journal of Experimental Drugs: “The various faces of the anti-COVID immune response.”

UCSF: “Ask the Professional: Looking for Immunity In opposition to COVID-19.”

La Jolla Institute for Immunology: “T Cells Take the Lead in Controlling SARS-COV-2 and Decreasing Covid-19 Severity.”

Cell: “Antigen-Particular Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Illness Severity.”

Immunity: “Immunology of COVID-19: Present State of the Science.”

The Lancet Infectious Ailments: “Genomic proof for reinfection with SARS-CoV-2: a case examine,” and “What reinfections imply for COVI-19.”

Johns Hopkins Coronavirus Useful resource Heart.

The Lancet Infectious Illness: “Longitudinal antibody and T cell responses in Ebola virus illness survivors and contacts: an observational cohort examine.”

mBio: “Decline of Humoral Responses in opposition to SARS-CoV-2 Spike in Convalescent People.”

Science Immunology: “Persistence and decay of human antibody response to the receptor binding area of SARS-CoV-2 spike protein in COVID-19 sufferers.”

BRO Information: “COVID-19 reinfection tracker.”